Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 2/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL10772569 | 0.96 | POLB (0.48) | POLBKMT2AMEN1L3MBTL1KDM4E | |
| SCHEMBL12002660 | 0.94 | POLB (0.47) | POLBKMT2AMEN1L3MBTL1KDM4E | |
| SCHEMBL8403545 | 0.87 | POLB (0.61) | POLBKMT2AHPGDLMNAHTT | |
| SCHEMBL10140682 | 0.83 | KMT2A (0.49) | KMT2AMEN1L3MBTL1KDM4EGLA | |
| SCHEMBL2949926 | 0.81 | MAPK1 (0.47) | POLBKMT2AMEN1L3MBTL1KDM4E | |
| SCHEMBL9515183 | 0.81 | POLB (0.52) | POLBKMT2AHPGDLMNAHTT | |
| SCHEMBL1449785 | 0.80 | MEN1 (0.52) | KMT2AMEN1L3MBTL1KDM4EGLA | |
| SCHEMBL10775630 | 0.80 | POLB (0.55) | POLBKMT2AL3MBTL1KDM4EHPGD | |
| SCHEMBL10439461 | 0.80 | L3MBTL1 (0.47) | POLBKMT2AMEN1L3MBTL1KDM4E | |
| SCHEMBL28550460 | 0.80 | PTGS1 (0.45) | POLBKMT2AMEN1L3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 525 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115925527-B | Method for preparing alpha-diaryl methyl substituted ketone compound | 湖南理工学院 | 2024-02-09 | — | — | CN | claimed |
| CN-115925527-A | Method for preparing alpha-diaryl methyl substituted ketone compound | 湖南理工学院 | 2023-04-07 | — | — | CN | claimed |
| CN-104710256-B | Cheap and efficient synthesis method of alpha-hydroxyketone compound | 北京大学 | 2017-03-22 | — | — | CN | claimed |
| EP-4720038-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2026-04-08 | — | — | EP | disclosed |
| US-12503452-B2 | Antimicrobial compounds and methods | CURZA GLOBAL, LLC (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250381196-A1 | ALPHA PROTEIN KINASE 1 INHIBITORS FOR USE IN TREATING KIDNEY DISEASES AND KIDNEY-RELATED DISEASES | SHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD (CN) | 2025-12-18 | — | — | US | disclosed |
| US-20250241908-A1 | ALPHA PROTEIN KINASE 1 INHIBITORS FOR USE IN TREATING ATHEROSCLEROSIS AND RELATED DISEASES | NINGBO MEISHAN BONDED PORT AREA ZHEJIANG UNITED INVESTMENT MANAGEMENT CO., LTD. (CN) | 2025-07-31 | — | — | US | disclosed |
| WO-2025136811-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | IDEAYA BIOSCIENCES, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-119859135-A | Rayleigh Lu Geli intermediate and preparation method thereof | 浙江工业大学 | 2025-04-22 | — | — | CN | disclosed |
| CN-119638663-A | Flavone derivative and microwave preparation method and application thereof | 延边大学 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024246496-A1 | (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES | Neophore Limited (GB) | 2024-12-05 | — | — | WO | disclosed |
| US-5482966-A | LIPOXYGENASE ENZYME INHIBITORS AS ANTIINFLAMMATORY AGENTS | ZENECA LIMITED (GB) | 1996-01-09 | — | — | US | disclosed |
| US-5332757-A | Enzyme inhibitors | ZENECA LIMITED (GB) | 1994-07-26 | — | — | US | disclosed |
| EP-0555068-A1 | Oxime derivatives as 5-lipoxygenase inhibitors | ZENECA LIMITED (GB) | 1993-08-11 | — | — | EP | disclosed |
| US-4980268-A | POLYAMIC ACID CONVERTIBLE TO POLYIMIDES | CIBA-GEIGY CORPORATION (US) | 1990-12-25 | — | — | US | disclosed |
| EP-0233686-A2 | Bis phenyl ethanol amines and bis phenyoxypropanolamines having a beta-agonist activity | BEECHAM GROUP PLC (GB) | 1987-08-26 | — | — | EP | disclosed |
| US-4345073-A | 7,7'-Diamino derivatives of 2,2'-spirodibenzopyranes | BASF AKTIENGESELLSCHAFT (DE) | 1982-08-17 | — | — | US | disclosed |
| US-4316027-A | DYE INTERMEDIATES USED IN THE MANUFACTURE OF PRESSURE SENSITIVE RECORDING MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | disclosed |
| US-4110348-A | PRESSURE SENSITIVE RECORDING | BASF AKTIENGESELLSCHAFT (DE) | 1978-08-29 | — | — | US | disclosed |
| US-3998971-A | Novel N-vinyloxyethyl-α-methyl-β-phenethylamines for depressing appetite | ABBOTT LABORATORIES (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250241908-A1 | ALPHA PROTEIN KINASE 1 INHIBITORS FOR USE IN TREATING ATHEROSCLEROSIS AND RELATED DISEASES | PHKA1, PHKA2, PHKG1 | POLB 1287/4885KMT2A 2582/4885MEN1 3169/4885 |
| US-20250381196-A1 | ALPHA PROTEIN KINASE 1 INHIBITORS FOR USE IN TREATING KIDNEY DISEASES AND KIDNEY-RELATED DISEASES | PHKA1, PHKA2, PHKG1 | POLB 2248/4885KMT2A 2191/4885MEN1 3121/4885 |
| US-12503452-B2 | Antimicrobial compounds and methods | MPO, NISCH, RPN2 | POLB 108/4885KMT2A 4067/4885MEN1 4216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.